AR and prostate carcinoma: By integrating spatial transcriptomics with multiplexed IF, this study revealed spatially distinct neuroendocrine (NE) cell populations emerging from KRT8+ luminal progenitors, which transit into heterogeneous ASCL1+ NE prostate cancer (NEPC) regions resistant to androgen receptor inhibitors.